Vivo Opportunity Fund Holdings, L.P. and Affiliates' Ownership in Camp4 Therapeutics Corp

Vivo Opportunity Fund Holdings, L.P. and its affiliates, including Vivo Opportunity, LLC, Vivo Opportunity Cayman Fund, L.P., and Vivo Opportunity Cayman, LLC, have filed a Schedule 13G to report their beneficial ownership in Camp4 Therapeutics Corp. Vivo Opportunity Fund Holdings, L.P. beneficially owns 3,561,793 shares of Common Stock, representing 7.6% of the class. Vivo Opportunity, LLC, as the general partner of Vivo Opportunity Fund Holdings, L.P., also holds the same number of shares. Vivo Opportunity Cayman Fund, L.P. owns 359,775 shares, representing 0.8% of the class, and Vivo Opportunity Cayman, LLC, as its general partner, holds the same number of shares. The filing certifies that the securities were not acquired for the purpose of influencing the control of the issuer. The filing is made pursuant to Rule 13d-1(c).